- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Apolipoprotein may have potential protective role in paediatric sepsis
Sepsis characterized by dysregulation of body's response to infection stands as the main cause of mortality in children.Despite the numerous clinical trials conducted, the quest for effective drugs to combat sepsis remains an immensely challenging undertaking.
Apolipoprotein H (APOH), also known as beta-2-glycoprotein I (β2-GPI), is a highly abundant plasma protein with a molecular size of approximately 50 kDa. It is primarily synthesized by liver cells and comprises five domains (I–V).It is a critical plasma protein that plays a crucial role in regulating various biological processes. However, its precise role in the immunopathology of paediatric sepsis remains unclear.
Recent research paper investigates the potential role of Apolipoprotein H (APOH) in pediatric sepsis. The study evaluated the concentration of APOH in pediatric patients with sepsis and healthy individuals, and the impact of APOH on survival, organ injury, and inflammation in a clinically relevant sepsis model induced by caecal ligation and puncture (CLP). The findings indicated that APOH levels were decreased in patients with sepsis compared to healthy controls, and lower APOH levels were associated with higher mortality rates. Additionally, the therapeutic intervention with recombinant APOH protein lowered the mortality rate, mitigated organ injury, and suppressed inflammation in mice with severe sepsis. In contrast, neutralizing APOH with an anti-APOH monoclonal antibody increased the mortality rate and exacerbated organ injury. The study also demonstrated that APOH inhibited M1 polarization in macrophages by suppressing the toll-like receptor 4 (TLR4)/nuclear factor-κB (NF-κB) signaling pathway, without directly affecting bacterial burden, neutrophil, and macrophage counts. The authors concluded that APOH has a protective role in the host defense response to sepsis and highlighted its potential therapeutic value in sepsis treatment. This study provides valuable insights into the potential role of APOH in modulating the immunopathology of pediatric sepsis and the underlying molecular mechanisms.
Reference –
Yu, Z., Xiao, C., Liu, R. et al. The protective effect of apolipoprotein H in paediatric sepsis. Crit Care 28, 36 (2024). https://doi.org/10.1186/s13054-024-04809-2
MBBS, MD (Anaesthesiology), FNB (Cardiac Anaesthesiology)
Dr Monish Raut is a practicing Cardiac Anesthesiologist. He completed his MBBS at Government Medical College, Nagpur, and pursued his MD in Anesthesiology at BJ Medical College, Pune. Further specializing in Cardiac Anesthesiology, Dr Raut earned his FNB in Cardiac Anesthesiology from Sir Ganga Ram Hospital, Delhi.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751